Inhibrx Biosciences Inc (INBX)
SG&A Expense Growth
-81.79%
Fiscal year · Period ending:
INBX SG&A Expense Growth
Latest reported-81.79%period ending
Latest reported-81.79%period ending
INBX FY SG&A Growth (YoY) (0.00% → -81.79%)
Latest values, visible window
High-resolution chart · PNG
INBX sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| -81.7857% | |
| 335.3324% | |
| 39.0948% | |
| 118.5063% | |
| 41.4131% | |
| -24.1961% | |
| 93.7688% | |
| 78.3825% | |
| 66.3903% | |
| 0% |